| pubmed-article:2723617 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2723617 | lifeskim:mentions | umls-concept:C0019163 | lld:lifeskim |
| pubmed-article:2723617 | lifeskim:mentions | umls-concept:C0072392 | lld:lifeskim |
| pubmed-article:2723617 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:2723617 | pubmed:dateCreated | 1989-7-7 | lld:pubmed |
| pubmed-article:2723617 | pubmed:abstractText | Two reactive sequences of the pre-S regions of hepatitis B surface antigen were synthesized chemically and used in micro-ELISAs for the assay of pre-S1 and pre-S2 antigens in serum from patients with acute and chronic hepatitis B. Pre-S1 antigen correlated well with the presence of HBV-DNA and was no longer detectable on cessation of viral replication, after natural recovery and after successful treatment with alpha-interferon. Pre-S2 proteins were also lost after treatment with alpha-interferon. The results show that the assay of pre-S1 and pre-S2 proteins in serum provides additional useful markers for assessing patients with acute and chronic hepatitis B infection and for monitoring the response to treatment with interferon. | lld:pubmed |
| pubmed-article:2723617 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2723617 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2723617 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2723617 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2723617 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2723617 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2723617 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2723617 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2723617 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2723617 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2723617 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2723617 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2723617 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2723617 | pubmed:month | May | lld:pubmed |
| pubmed-article:2723617 | pubmed:issn | 0146-6615 | lld:pubmed |
| pubmed-article:2723617 | pubmed:author | pubmed-author:ZuckermanA... | lld:pubmed |
| pubmed-article:2723617 | pubmed:author | pubmed-author:ThomasH CHC | lld:pubmed |
| pubmed-article:2723617 | pubmed:author | pubmed-author:ColemanJ CJC | lld:pubmed |
| pubmed-article:2723617 | pubmed:author | pubmed-author:KarayiannisPP | lld:pubmed |
| pubmed-article:2723617 | pubmed:author | pubmed-author:KuijpersLL | lld:pubmed |
| pubmed-article:2723617 | pubmed:author | pubmed-author:ZanettiAA | lld:pubmed |
| pubmed-article:2723617 | pubmed:author | pubmed-author:HarrisonT JTJ | lld:pubmed |
| pubmed-article:2723617 | pubmed:author | pubmed-author:CargnelAA | lld:pubmed |
| pubmed-article:2723617 | pubmed:author | pubmed-author:Murray-LyonII | lld:pubmed |
| pubmed-article:2723617 | pubmed:author | pubmed-author:KoensMM | lld:pubmed |
| pubmed-article:2723617 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2723617 | pubmed:volume | 28 | lld:pubmed |
| pubmed-article:2723617 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2723617 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2723617 | pubmed:pagination | 47-51 | lld:pubmed |
| pubmed-article:2723617 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:2723617 | pubmed:meshHeading | pubmed-meshheading:2723617-... | lld:pubmed |
| pubmed-article:2723617 | pubmed:meshHeading | pubmed-meshheading:2723617-... | lld:pubmed |
| pubmed-article:2723617 | pubmed:meshHeading | pubmed-meshheading:2723617-... | lld:pubmed |
| pubmed-article:2723617 | pubmed:meshHeading | pubmed-meshheading:2723617-... | lld:pubmed |
| pubmed-article:2723617 | pubmed:meshHeading | pubmed-meshheading:2723617-... | lld:pubmed |
| pubmed-article:2723617 | pubmed:meshHeading | pubmed-meshheading:2723617-... | lld:pubmed |
| pubmed-article:2723617 | pubmed:meshHeading | pubmed-meshheading:2723617-... | lld:pubmed |
| pubmed-article:2723617 | pubmed:meshHeading | pubmed-meshheading:2723617-... | lld:pubmed |
| pubmed-article:2723617 | pubmed:meshHeading | pubmed-meshheading:2723617-... | lld:pubmed |
| pubmed-article:2723617 | pubmed:meshHeading | pubmed-meshheading:2723617-... | lld:pubmed |
| pubmed-article:2723617 | pubmed:meshHeading | pubmed-meshheading:2723617-... | lld:pubmed |
| pubmed-article:2723617 | pubmed:meshHeading | pubmed-meshheading:2723617-... | lld:pubmed |
| pubmed-article:2723617 | pubmed:meshHeading | pubmed-meshheading:2723617-... | lld:pubmed |
| pubmed-article:2723617 | pubmed:meshHeading | pubmed-meshheading:2723617-... | lld:pubmed |
| pubmed-article:2723617 | pubmed:year | 1989 | lld:pubmed |
| pubmed-article:2723617 | pubmed:articleTitle | Pre-S proteins in hepatitis B. | lld:pubmed |
| pubmed-article:2723617 | pubmed:affiliation | Scientific Development Group, Organon International BV, Oss, Netherlands. | lld:pubmed |
| pubmed-article:2723617 | pubmed:publicationType | Journal Article | lld:pubmed |
